泉州市华滋生物科技有限公司成立,注册资本500万人民币
Sou Hu Cai Jing·2026-01-21 16:02

Core Viewpoint - Quanzhou Huazi Biotechnology Co., Ltd. has been established with a registered capital of 5 million RMB, focusing on various technology and health-related services [1] Company Overview - The legal representative of Quanzhou Huazi Biotechnology Co., Ltd. is Wu Weimin [1] - The company is wholly owned by Quanzhou Dexin Enterprise Management Co., Ltd. [1] - The registered capital is 5 million RMB [1] Business Scope - The business scope includes research and development of IoT technology, digital technology services, digital advertising publishing and design, internet sales (excluding licensed products), wholesale and retail of cosmetics, sales of sanitary products and disposable medical supplies, personal hygiene products, and disinfectants (excluding hazardous chemicals) [1] - The company is also involved in licensed projects such as drug production, wholesale and retail, entrusted production, internet information services for drugs, cosmetics production, sales of disinfecting devices, and disinfectant production (excluding hazardous chemicals) [1] Company Classification - Quanzhou Huazi Biotechnology Co., Ltd. is classified as a limited liability company (wholly owned by a natural person) [1] - The business term is set from January 20, 2026, to an indefinite period [1] - The company is registered under the scientific research and technical service industry, specifically in technology promotion and application services [1]

泉州市华滋生物科技有限公司成立,注册资本500万人民币 - Reportify